Noramco, founded in 1979 and headquartered in Delaware, is a leading specialty active pharmaceutical ingredient (API) development and manufacturing company with operations worldwide. Specializing in controlled substance development, they provide DEA compliant security and production capacity for a range of therapeutic applications, from kilos to multi-ton supply.
With a focus on advancing science and delivering solutions, Noramco is a trusted partner to the pharmaceutical industry, offering high-purity controlled substances and custom synthesis services. Their expertise in addiction treatment and abuse prevention products, such as the Nal family of compounds and ADHD stimulants, demonstrates a long-term commitment to innovation and quality in API manufacturing.
Generated from the website